Kamfarma Sa

Kamfarma, founded in 1978, is a Swiss Pharmaceutical Company interested in bringing in new investors from Biopharma, active family controlled pharmaceutical businesses, Pharmaceutical Leading Investing Distributors and Leading FDA, EU, Anvisa API Manufacturers to mitigate risk and participate in the Development of specialty complex pharmaceutical products, first to file, through either novel API synthesis, challenging clinical end points or unmet medical needs. Our entrepreneurial style does not have a specific therapeutic focus or market demographic or segment, up to date the USA is the Core Territory before globalizing followed by Europe, Russia, MENA, Japan and rest of the World.